Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - quinine sulfate dihydrate, quantity: 300 mg - tablet, film coated - excipient ingredients: lactose monohydrate; maize starch; povidone; sodium starch glycollate; magnesium stearate; titanium dioxide; hypromellose; macrogol 400 - prevention and symptomatic relief of muscle cramps. symptomatic relief of myotonia congenita. suppression of malaria. indications as at 21 january 2004. suppression of malaria. indications as at 26 april 2004. suppression of malaria.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - quinine sulfate dihydrate 300mg; quinine sulfate dihydrate 300mg - film coated tablet - 300 mg - active: quinine sulfate dihydrate 300mg excipient: carnauba wax chloroform diethyl phthalate ethanol hypromellose lactose monohydrate magnesium stearate povidone sodium starch glycolate active: quinine sulfate dihydrate 300mg excipient: carnauba wax diethyl phthalate ethanol hypromellose lactose monohydrate magnesium stearate povidone purified water sodium starch glycolate

United States - English - NLM (National Library of Medicine)

riconpharma llc - quinine sulfate (unii: kf7z0e0q2b) (quinine - unii:a7v27phc7a) - quinine sulfate 324 mg

United States - English - NLM (National Library of Medicine)

ingenus pharmaceuticals nj, llc - quinine sulfate (unii: kf7z0e0q2b) (quinine - unii:a7v27phc7a) - quinine sulfate 324 mg

United States - English - NLM (National Library of Medicine)

corepharma, llc - quinine sulfate (unii: kf7z0e0q2b) (quinine - unii:a7v27phc7a) - quinine sulfate 324 mg

United States - English - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - quinine sulfate (unii: kf7z0e0q2b) (quinine - unii:a7v27phc7a) - quinine sulfate 324 mg

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - quinine sulfate dihydrate, quantity: 300 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; lactose monohydrate; maize starch; colloidal anhydrous silica; purified talc; magnesium stearate; sodium starch glycollate; carnauba wax; titanium dioxide; hypromellose; macrogol 4000 - for symptomatic relief of nocturnal leg cramps. treatment of malaria due to strains of p. falciparum resistant to chloroquine and the related 4-aminoquinolines. the synthetic antimalarials are in general more effective and less toxic than quinine. indications as at 20 february 2004: treatment of malaria due to strains of p. falciparum resistant to chloroquine and the related 4-aminoquinolines. the synthetic antimalarials are in general more effective and less toxic than quinine. indications as at 26 april 2004: treatment of malaria due to strains of p. falciparum resistant to chloroquine and the related 4-aminoquinolines. the synthetic antimalarials are in general more effective and less toxic than quinine.

New Zealand - English - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - quinine sulfate dihydrate 300mg - film coated tablet - 300 mg - active: quinine sulfate dihydrate 300mg

New Zealand - English - Medsafe (Medicines Safety Authority)

apotex nz ltd - quinine sulfate dihydrate 200mg - film coated tablet - 200 mg - active: quinine sulfate dihydrate 200mg excipient: magnesium stearate

New Zealand - English - Medsafe (Medicines Safety Authority)

apotex nz ltd - quinine sulfate dihydrate 300mg - film coated tablet - 300 mg - active: quinine sulfate dihydrate 300mg excipient: magnesium stearate